We are monitoring the impact of COVID-19 on APAC Orthobiologics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7104
Share on
Share on

Asia Pacific Orthobiologics Market Research Report – Segmented By Product, Application, End Users Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 7104
Pages: 145

APAC Orthobiologics Market Size (2021 to 2026)

The size of the Orthobiologics Market in the Asia Pacific is estimated to be worth USD 1.62 billion by 2026 and USD 1.20 billion in 2021, growing at a CAGR of 6.23% during the forecast period.

Orthobiologics, also known as a regenerative cellular treatment, is a technique surgeons use to help them heal wounds quicker. Orthobiologics helps with tissue repair and pain stimulation. Broken bones, muscles, and ligaments are treated with orthobiologics.

Increased focus on medical device research and development, adoption of new healthcare technologies, and rising investment in healthcare infrastructure development, particularly in developing nations, are significant factors contributing to the growth of the APAC orthobiologics market.

An increase in the prevalence of a wide range of orthopedic and lifestyle problems around the APAC region is another key factor accelerating the market’s growth. In addition, a growing focus on healthcare technological breakthroughs, along with an ever-increasing geriatric population, is anticipated to be the market growth determinant. In addition, the growing number of hospitals and diagnostic centers and raising public awareness of the benefits of orthobiologics are expected to create lucrative market growth prospects.

The high costs of orthopedic implants, on the other hand, are expected to slow the market’s growth during the forecast period. Furthermore, the market is forecasted to face additional obstacles due to a lack of medical specialists, particularly in developing and undeveloped nations, and government-imposed rules. In addition, post-surgery difficulties are expected to inhibit the growth rate of the market.

Impact of COVID-19 on the APAC orthobiologics market:

The orthobiologics market has seen a decline in growth due to the COVID-19 pandemic in the APAC region. The worldwide supply chain has been interrupted as a result of the lockout. All medical procedures were postponed or canceled during this time due to the crisis, except for emergency patients. As a result, the industry’s market share has decreased. Telemedicine services were crucial in delivering care during the outbreak.

This research report on the APAC Orthobiologics Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Viscosupplementation
  • Demineralized Bone Matrices
  • Synthetic Orthobiologics
  • Bone Morphogenic Protein
  • Allografts
  • Plasma-Rich Protein
  • Bone Marrow Aspirate Concentrate

By Application: 

  • Osteoarthritis and Degenerative Arthritis
  • Spinal Fusion
  • Fracture Recovery
  • Soft Tissue Injuries
  • Maxillofacial & Dental Applications

By End Users: 

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Care Centres
  • Research and Academic Institutes
  • Dental Clinics & Facilities

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, Asia Pacific has the third-largest market for orthobiologics in the world by share. It is also the fastest-growing region in the world. Factors such as the growing incidence of musculoskeletal and orthopedic diseases and rising government support are expected to drive the market growth in the region. In addition, growing disposable income, a rising number of hospitals, growing awareness of the benefits of these products among doctors and patients, and improving healthcare standards are estimated to act as a plus to the market's growth rate.

 

The China orthobiologics market had the largest share in the APAC market in 2020. The market in this geographic area is predicted to develop even more due to increased research and the country’s aging population.

The Indian orthobiologics market is expected to project a lucrative CAGR during the forecast period. However, due to increased demand for viscosupplements in India and an increase in the number of independent orthopedic clinics, Asia Pacific is expected to grow quickly during the forecast period.

The orthobiologics market in Japan is estimated to progress a steady CAGR from 2021 to 2026 due to the growing senior population and increased incidence of traffic accidents. Furthermore, the market growth in Japan is further likely to be fueled by factors such as the rising frequency of musculoskeletal and orthopedic illnesses.

KEY MARKET PLAYERS:

A few notable companies in the APAC Orthobiologics Market profiled in this report are Medtronic, DePuy Synthes, Zimmer Biomet, Bioventus, Stryker, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, among others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Viscosupplementation       

                                5.1.2 Products  

                                5.1.3 Demineralized Bone Matrices         

                                5.1.4 Synthetic Orthobiologics   

                                5.1.5 Bone Morphogenic Protein             

                                5.1.6 Allografts 

                                5.1.7 Plasma-Rich Protein            

                                5.1.8 Bone Marrow Aspirate Concentrate            

                                5.1.9  Y-o-Y Growth Analysis, By Product              

                                5.1.10  Market Attractiveness Analysis, By Product          

                                5.1.11  Market Share Analysis, By Product            

                5.2 Application                 

                                5.2.1 Osteoarthritis and Degenerative Arthritis  

                                5.2.2 Spinal Fusion          

                                5.2.3 Fracture Recovery               

                                5.2.4 Soft Tissue Injuries              

                                5.2.5 Maxillofacial & Dental Applications               

                                5.2.6 Y-o-Y Growth Analysis, By Application         

                                5.2.7 Market Attractiveness Analysis, By Application       

                                5.2.8 Market Share Analysis, By Application        

                5.3 End Users                    

                                5.3.1 Hospitals  

                                5.3.2 Orthopaedic Clinics              

                                5.3.3 Ambulatory Care Centres 

                                5.3.4 Research and Academic Institutes                

                                5.3.5 Dental Clinics & Facilities   

                                5.3.6 Y-o-Y Growth Analysis, By End Users           

                                5.3.7  Market Attractiveness Analysis, By End Users        

                                5.3.8  Market Share Analysis, By End Users          

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Product

                                                6.1.3.2 By Application

                                                6.1.3.3 By End Users

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Product

                                                6.1.4.2 By Application

                                                6.1.4.3 By End Users

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Product

                                                6.1.5.2 By Application

                                                6.1.5.3 By End Users

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Medtronic                   

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DePuy Synthes                         

                8.3 Zimmer Biomet                         

                8.4 Bioventus                    

                8.5 Stryker                         

                8.6 Harvest Technologies                             

                8.7 Globus                          

                8.8 Orthofix International                            

                8.9 RTI Surgical                 

                8.10 K2M Group                              

                8.11 Kuros Biosciences                  

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and  forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  2. Asia Pacific Viscosupplementation Market By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Products Market By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific DBM Market By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Synthetic Orthobiologics Market By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific BMP Market By Region, From 2021 to 2026 (USD Million)
  7. Asia Pacific Allografts Market By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific PRP  Market By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific BMAC Market By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
  11. Asia Pacific Osteoarthritis and Degenerative Arthritis Market By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Spinal Fusion Market By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Fracture Recovery Market By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Soft Tissue Injuries  Market By Region, From 2021 to 2026 (USD Million)
  15. Asia Pacific Maxillofacial & Dental Applications Market By Region, From 2021 to 2026 (USD Million)
  16. Asia Pacific Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)
  17. Asia Pacific Hospitals Market By Region, From 2021 to 2026 (USD Million)
  18. Asia Pacific Orthopaedic Clinics Market By Region, From 2021 to 2026 (USD Million)
  19. Asia Pacific Ambulatory Care Centres Market By Region, From 2021 to 2026 (USD Million)
  20. Asia Pacific Research and Academic Institutes Market By Region, From 2021 to 2026 (USD Million)
  21. Asia Pacific Dental Clinics & Facilities Market By Region, From 2021 to 2026 (USD Million)
  22. Japan Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  23. Japan Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
  24. Japan Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)
  25. China Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  26. China Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
  27. China Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)
  28. India Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  29. India Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
  30. India Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)
  31. Australia Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  32. Australia Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
  33. Australia Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)
  34. South Korea Orthobiologics Market, By Product , From 2021 to 2026 (USD Million)
  35. South Korea Orthobiologics Market, By Application , From 2021 to 2026 (USD Million)
    1. South Korea Orthobiologics Market, By End Users , From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample